文献速递认知障碍与痴呆帕金森病与运动障碍神经肌肉病

脑脊液神经丝轻链蛋白与痴呆、运动神经元病及运动障碍患者认知的关联

Association of Cerebrospinal Fluid Neurofilament Light Protein Levels With Cognition in Patients With Dementia, Motor Neuron Disease, and Movement Disorders.
PubMed 文献 · JAMA Neurol · 2019-01-01

这项病例对照研究纳入913名受试者,检测脑脊液神经丝轻链蛋白(NFL)水平,发现NFL从对照到轻度认知障碍再到阿尔茨海默病呈阶梯式升高,且与基线及纵向认知下降相关;NFL在肌萎缩侧索硬化中最高,并提高疾病鉴别准确性。

要点

  • 脑脊液NFL在AD和FTD中与认知损害及下降相关。
  • NFL在ALS中最高,PSP和CBD在帕金森综合征中较高。
  • NFL联合Aβ42、t-tau和p-tau可提高疾病鉴别准确性。

核心结论

  • 脑脊液NFL水平与阿尔茨海默病和额颞叶痴呆患者的认知损害相关。
  • 在其他神经退行性疾病中,NFL水平可能反映神经退行性过程的强度。

研究设计与样本

  • 认知测试随访1至18年(均值0.98年,SD2.25年),120名患者有尸检确诊诊断(14.2%)。

主要发现

  • 脑脊液NFL中位数从对照536 pg/mL升至MCI 831 pg/mL和AD 951 pg/mL,呈阶梯式升高。
  • NFL与基线MMSE评分负相关(ρ=-0.19,P<.001,n=822),与年评分下降正相关(ρ=0.36,P<.001)。
  • NFL在ALS中最高(中位数4185 pg/mL),FTD次之(2094 pg/mL),PSP为1578 pg/mL,CBD为1281 pg/mL。
  • NFL与17个脑区中13个的TDP-43负荷相关。
  • 将NFL加入Aβ42、t-tau和p-tau可提高疾病鉴别准确性。

临床怎么用

  • 脑脊液NFL可作为神经退行性变的辅助生物标志物,尤其用于AD和FTD认知损害的评估。
  • NFL联合AD核心标志物可能提高疾病鉴别诊断的准确性。

局限性

  • 仅14.2%的患者有尸检确诊诊断。
  • 认知随访平均时间较短(0.98年)。
  • 研究在单一中心进行。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Neuronal and axonal destruction are hallmarks of neurodegenerative diseases, but it is difficult to estimate the extent and progress of the damage in the disease process. OBJECTIVE: To investigate cerebrospinal fluid (CSF) levels of neurofilament light (NFL) protein, a marker of neuroaxonal degeneration, in control participants and patients with dementia, motor neuron disease, and parkinsonian disorders (determined by clinical criteria and autopsy), and determine its association with longitudinal cognitive decline. DESIGN, SETTING, AND PARTICIPANTS: In this case-control study, we investigated NFL levels in CSF obtained from controls and patients with several neurodegenerative diseases. Collection of samples occurred between 1996 and 2014, patients were followed up longitudinally for cognitive testing, and a portion were autopsied in a single center (University of Pennsylvania). Data were analyzed throughout 2016. EXPOSURES: Concentrations of NFL in CSF. MAIN OUTCOMES AND MEASURES: Levels of CSF NFL and correlations with cognition scores. RESULTS: A total of 913 participants (mean [SD] age, 68.7 [10.0] years; 456 [49.9%] women) were included: 75 control participants plus 114 patients with mild cognitive impairment (MCI), 397 with Alzheimer disease, 96 with frontotemporal dementia, 68 with amyotrophic lateral sclerosis, 41 with Parkinson disease (PD), 19 with PD with MCI, 29 with PD dementia, 33 with dementia with Lewy bodies, 21 with corticobasal syndrome, and 20 with progressive supranuclear palsy. Cognitive testing follow-up occurred for 1 to 18 years (mean [SD], 0.98 [2.25] years); autopsy-verified diagnoses were available for 120 of 845 participants with diseases (14.2%). There was a stepwise increase in CSF NFL levels between control participants (median [range] score, 536 [398-777] pg/mL), participants with MCI (831 [526-1075] pg/mL), and those with Alzheimer disease (951 [758-1261] pg/mL), indicating that NFL levels increase with increasing cognitive impairment. Levels of NFL correlated inversely with baseline Mini-Mental State Examination scores (ρ, -0.19; P < .001) in the full cohort (n = 822) and annual score decline in the full cohort (ρ, 0.36, P < .001), participants with AD (ρ, 0.25; P < .001), and participants with FTD (ρ, 0.46; P = .003). Concentrations of NFL were highest in participants with amyotrophic lateral sclerosis (median [range], 4185 [2207-7453] pg/mL) and frontotemporal dementia (2094 [230-7744] pg/mL). In individuals with parkinsonian disorders, NFL concentrations were highest in those with progressive supranuclear palsy (median [range], 1578 [1287-3104] pg/mL) and corticobasal degeneration (1281 [828-2713] pg/mL). The NFL concentrations in CSF correlated with TDP-43 load in 13 of 17 brain regions in the full cohort. Adding NFL to β-amyloid 42, total tau, and phosphorylated tau increased accuracy of discrimination of diseases. CONCLUSIONS AND RELEVANCE: Levels of CSF NFL are associated with cognitive impairments in patients with Alzheimer disease and frontotemporal dementia. In other neurodegenerative disorders, NFL levels appear to reflect the intensity of the neurodegenerative processes.

来源:JAMA Neurol,查看原文。版权归原作者所有。

引用

  1. Olsson B, Portelius E, Cullen NC, et al. Association of Cerebrospinal Fluid Neurofilament Light Protein Levels With Cognition in Patients With Dementia, Motor Neuron Disease, and Movement Disorders. JAMA Neurol. 2019. PMID: 30508027. doi:10.1001/jamaneurol.2018.3746

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。